Ticker Details
Keros Therapeutics, Inc.
IPO Date:	April 8, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$246.27M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.09 | 2.63%
Avg Daily Range (30 D):	$0.31 | 2.54%
Avg Daily Range (90 D):	$0.37 | 2.26%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.39M
Avg Daily Volume (90 D):	.36M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	2,120
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$1.36M
Avg Institutional Trade (90 D):	$1.69M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.92M
Avg Closing Trade (30 D):	$1.24M
Avg Closing Trade (90 D):	$1.67M
Avg Closing Volume:	61.02K

News

Mar 9, 2026 @ 12:00 PM Keros Therapeutics Presents Additional Clinical Da... Source: Na

Nov 20, 2025 @ 9:01 PM Keros Therapeutics Announces Final Results of Tend... Source: Globe Newswire

Nov 19, 2025 @ 11:00 AM Keros Therapeutics Announces Preliminary Results o... Source: Keros Therapeutics, Inc.

Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight

May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.34	$-.38	$2.34
Diluted EPS	$2.3	$-.38	$2.3
Revenue	$243.86M	$.38M	$243.86M
Gross Profit
Net Income / Loss	$87.01M	$-23.46M	$87.01M
Operating Income / Loss	$67.57M	$-29.27M	$67.57M
Cost of Revenue
Net Cash Flow	$-272.52M	$-406.06M	$-272.52M
PE Ratio	4.87